Detection of VEGF-Axxxb Isoforms in Human Tissues

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Bates, David O ^a   Mavrou, Athina ^a   Qiu, Yan ^a   Carter, James G ^a   Hamdollah Zadeh, Maryam ^a   Barratt, Shaney ^a   Gammons, Melissa V ^a   Millar, Ann B ^a   Salmon, Andrew H J ^a   Oltean, Sebastian ^a   Harper, Steven J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; ISOPROTEIN; MESSENGER RNA; SMALL INTERFERING RNA; VASCULOTROPIN A; VASCULOTROPIN ANTIBODY; VASCULOTROPIN B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOPRECIPITATION; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL;

ALTERNATIVE SPLICING; ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; DNA PRIMERS; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOPRECIPITATION; MICE; PROTEIN ISOFORMS; REFERENCE STANDARDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84881168531     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068399     Document Type: Article

References (36)

1. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, et al. (1991) The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5: 1806-1814.
2. Harper SJ, Bates DO, (2008) VEGF-A splicing: the key to anti-angiogenic therapeutics? Nat Rev Cancer 8: 880-887.
3. Bates DO, Cui TG, Doughty JM, Winkler M, Sugiono M, et al. (2002) VEGF-A165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res 62: 4123-4131.
4. Rennel E, Varey AHR, Churchill AJ, Wheatley ER, Stewart L, et al. (2009) VEGF121b, a new member of the VEGFxxxb family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo. Br J Cancer 101: 1250-1257.
5. Miller-Kasprzak E, Jagodzinski PP, (2008) 5-Aza-2′-deoxycytidine increases the expression of anti-angiogenic vascular endothelial growth factor 189b variant in human lung microvascular endothelial cells. Biomed Pharmacother 62: 158-163.
6. Perrin RM, Konopatskaya O, Qiu Y, Harper S, Bates DO, et al. (2005) Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor. Diabetologia 48: 2422-2427.
7. Woolard J, Wang WY, Bevan HS, Qiu Y, Morbidelli L, et al. (2004) VEGF-A165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res 64: 7822-7835.
8. Schumacher VA, Jeruschke S, Eitner F, Becker JU, Pitschke G, et al. (2007) Impaired glomerular maturation and lack of VEGF-A165b in Denys-Drash syndrome. J Am Soc Nephrol 18: 719-729.
9. Michels D, Rennel ES, Feltgen N, Martin G, Stahl A, et al. (2008) Enhanced levels of VEGF and reduced levels of VEGFxxxb in the vitreous of patients with retinal vein occlusion. Acta Ophthalmol Scand 86: 59.
10. Manetti M, Guiducci S, Romano E, Ceccarelli C, Bellando-Randone S, et al. (2011) Overexpression of VEGF-A165b, an Inhibitory Splice Variant of Vascular Endothelial Growth Factor, Leads to Insufficient Angiogenesis in Patients With Systemic Sclerosis. Circ Res 109: e14-26.
11. Simpson A, Custovic A, Tepper R, Graves P, Stern DA, et al. (2012) Genetic variation in vascular endothelial growth factor-a and lung function. Am J Respir Crit Care Med 185: 1197-1204.
12. Nowak DG, Amin EM, Rennel ES, Hoareau-Aveilla C, Gammons M, et al. (2010) Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis. J Biol Chem 285: 5532-5540.
13. Amin EM, Oltean S, Hua J, Gammons MV, Hamdollah-Zadeh M, et al. (2011) WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing. Cancer Cell 20: 768-780.
14. Nowak DG, Woolard J, Amin EM, Konopatskaya O, Saleem MA, et al. (2008) Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by known splicing and growth factors. J Cell Sci 121: 3487-3495.
15. Varey AH, Rennel ES, Qiu Y, Bevan HS, Perrin RM, et al. (2008) VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. Br J Cancer 98: 1366-1379.
16. Baba T, McLeod DS, Edwards MM, Merges C, Sen T, et al. (2011) VEGF(165) b in the developing vasculatures of the fetal human eye. Dev Dyn.
17. Venables JP, (2006) Unbalanced alternative splicing and its significance in cancer. Bioessays 28: 378-386.
18. Sugnet CW, Kent WJ, Ares M, Jr. Haussler D (2004) Transcriptome and genome conservation of alternative splicing events in humans and mice. Pac Symp Biocomput: 66-77.
19. Zhang XH, Chasin LA, (2006) Comparison of multiple vertebrate genomes reveals the birth and evolution of human exons. Proc Natl Acad Sci U S A 103: 13427-13432.
20. Thanaraj TA, Clark F, Muilu J, (2003) Conservation of human alternative splice events in mouse. Nucleic Acids Res 31: 2544-2552.
21. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, et al. (2002) Initial sequencing and comparative analysis of the mouse genome. Nature 420: 520-562.
22. Xu J, Dou T, Liu C, Fu M, Huang Y, et al. (2011) The evolution of alternative splicing exons in vascular endothelial growth factor A. Gene. 487: 143-150.
23. Harris S, Craze M, Newton J, Fisher M, Shima DT, et al. (2012) Do anti-angiogenic VEGF (VEGFxxxb) isoforms exist? A cautionary tale. PLoS One 7: e35231.
24. Woolard J, Vousden W, Moss SJ, Krishnakumar A, Gammons MV, et al. (2011) Borrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoforms. Chem Sci 2011: 273-278.
25. Rennel E, Waine E, Guan H, Schuler Y, Leenders W, et al. (2008) The endogenous anti-angiogenic VEGF isoform, VEGF-A165b inhibits human tumour growth in mice. Br J Cancer 98: 1250-1257.
26. Pritchard-Jones RO, Dunn DB, Qiu Y, Varey AH, Orlando A, et al. (2007) Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma. Br J Cancer 97: 223-230.
27. Jordana M, Schulman J, McSharry C, Irving LB, Newhouse MT, et al. (1988) Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. Am Rev Respir Dis 137: 579-584.
28. Williams AC, Harper SJ, Paraskeva C, (1990) Neoplastic transformation of a human colonic epithelial cell line: in vitro evidence for the adenoma to carcinoma sequence. Cancer Res 50: 4724-4730.
29. Ehlken C, Rennel ES, Michels D, Grundel B, Pielen A, et al. (2010) Levels of VEGF but not VEGF(165b) are increased in the vitreous of patients with retinal vein occlusion. Am J Ophthalmol 152: 298-303 e291.
30. Varet J, Douglas SK, Gilmartin L, Medford AR, Bates DO, et al. (2010) VEGF in the lung: a role for novel isoforms. Am J Physiol Lung Cell Mol Physiol 298: L768-774.
31. Cui TG, Foster RR, Saleem M, Mathieson PW, Gillatt DA, et al. (2004) Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF-A165b) mRNA and protein. Am J Physiol Renal Physiol 286: F767-773.
32. Ergorul C, Ray A, Huang W, Darland D, Luo ZK, et al. (2008) Levels of vascular endothelial growth factor-A165b (VEGF-A165b are elevated in experimental glaucoma. Mol Vis 14: 1517-1524.
33. Peiris-Pages M, Harper SJ, Bates DO, Ramani P, (2010) Balance of pro- versus anti-angiogenic splice isoforms of vascular endothelial growth factor as a regulator of neuroblastoma growth. J Pathol 222: 138-147.
34. McFee RM, Rozell TG, Cupp AS, (2012) The balance of proangiogenic and antiangiogenic VEGFA isoforms regulate follicle development. Cell Tissue Res 349: 635-647.
35. Bates DO, Catalano PJ, Symonds KE, Varey AHR, Ramani P, et al. (2012) Association Between VEGF Splice Isoforms And Progression Free Survival In Metastatic Colorectal Cancer Patients Treated With Bevacizumab. Clin Cancer Res in press.
36. Ballmer-Hofer K, Andersson AE, Ratcliffe LE, Berger P (2011) Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output. Blood.